Regulation of mRNA expression in drug-sensitive and drug-resistant gastric carcinoma cells is independent of YB-1 expression

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 693-698

  Kurucz, Reka ^a   Belian, Elisa ^a   Treue, Denise ^a   Lage, Hermann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Gene expression; Gene regulation; RNA interference; YB 1

Indexed keywords

MESSENGER RNA; SHORT HAIRPIN RNA; TETRACYCLINE; Y BOX BINDING PROTEIN 1;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CARCINOMA;

ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, NORTHERN; BLOTTING, WESTERN; DAUNORUBICIN; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77950523605     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kohno K, Izumi H, Uchiumi T, Ashizuka M and Kuwano M: The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25: 691-698, 2003.
2. Wu J, Startford AL, Astanehe A and Dunn SE: YB-1 is a transcrition/translation factor that orchestrates the oncogenome by hardwiring signal transduction to gene expression. Transl Oncogenom 2: 49-65, 2007.
3. Didier DK, Schiffenbauer J, Woulfe SL, Zacheis M and Schwartz BD: Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci USA 85: 7322-7326, 1988.
4. Ranjan M, Tafuri SR and Wolffe AP: Masking mRNA from translation in somatic cells. Genes Dev 7: 1725-1736, 1993.
5. Bader AG, Kang S, Zhao L and Vogt PK: Oncogenic PI3K deregulates transcription and translation. Nat Reverse Cancer 5: 921-929, 2005.
6. Bergmann S, Royer-Pokora B, Fietze E, Jürchott K, Hildebrandt B, Trost D, Leenders F, Claude JC, Theuring F, Bargou R, Dietel M and Royer HD: YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 65: 4078-4087, 2005.
7. Fujii T, Kawahara A, Basaki Y, Hattori S, Nakashima K, Nakano K, Shirouzu K, Kohno K, Yanagawa T, Yamana H, Nishio K, Ono M, Kuwano M and Kage M: Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers. Cancer Res 68: 1504-1512, 2008.
8. Bargou RC, Jürchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara MY, Winzer KJ, Dietel M, Dörken B and Royer HD: Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDRl gene expression. Nat Med 3: 447-450, 1997.
9. Janz M, Harbeck N, Dettmar P, Berger U, Schmidt A, Jürchott K, Schmitt M and Royer HD: Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int J Cancer 97: 278-282, 2002.
10. Kaszubiak A, Kupstat A, Müller U, Hausmann R, Hohn PS and Lage H: Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1. Biochem Biophys Res Commun 357: 295-301, 2007.
11. Dietel M, Arps H, Lage H and Niendorf A: Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res 50: 6100-6106, 1990.
12. Lage H: Molecular analysis of therapy resistance in gastric cancer. Dig Dis 21: 326-338, 2003.
13. van de Wetering M, Oving I, Muncan V, Tjon Pon Fong M, Brantjes H, van Leenen D, Holstege FCP, Brummelkamp TR, Agami R and Clevers H: Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4: 609-615, 2003.
14. Norman JT, Lindahl GE, Shakib K, En-Nia A, Yilmaz E and Mertens PR: The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily consereverseerseed regulatory element in the proximal promoter. J Biol Chem 276: 29880-29890, 2001.
15. Mertens PR, Harendza S, Pollock AS and Lovett DH: Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem 272: 22905-22912, 1997.
16. Okamoto T, Izumi H, Imamura T, Takano H, Ise T, Uchiumi T, Kuwano M and Kohno K: Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene 19: 6194-6202, 2000.
17. Dallas PB, Gottardo NG, Firth MJ, Beesley AH, Hoffmann K, Terry PA, Freitas JR, Boag JM, Cummings AJ and Kees UR: Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? BMC Genomics 6: 59, 2005.
18. Draghici S, Khatri P, Eklund AC and Szallasi Z: Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 22: 101-109, 2006.
19. Watson SJ, Meng F, Thompson RC and Akil H: The 'chip' as a specific genetic tool. Biol Psychiatry 48: 1147-1156, 2000.
20. Warrington JA, Nah A, Mahadevappa M and Tsyganskaya M: Comparison of human adult and fetal expression and identification of 535 housekeeping/ maintenance genes. Physiol Genomics 2: 143-714, 2000.